Biotech, Canada, clinical trial, FDA, Harvard, Health, IBS, irritable bowel syndrome, Massachusetts, News, pain, Psilocybin, psychedelic therapy, Psychedelics, psychotherapy
Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment
26
May
May
Tryp Therapeutics announced on Wednesday that it had “submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its planned Phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from Irritable Bowel Syndrome (IBS) at Massachusetts General Hospital (MGH).” The […]